• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RELN 多态性及其表达在耳硬化症发展中的风险。

The risks of RELN polymorphisms and its expression in the development of otosclerosis.

机构信息

Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, India.

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.

出版信息

PLoS One. 2022 Jun 3;17(6):e0269558. doi: 10.1371/journal.pone.0269558. eCollection 2022.

DOI:10.1371/journal.pone.0269558
PMID:35658052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9165908/
Abstract

Otosclerosis (OTSC) is the primary form of conductive hearing loss characterized by abnormal bone remodelling within the otic capsule of the human middle ear. A genetic association of the RELN SNP rs3914132 with OTSC has been identified in European population. Previously, we showed a trend towards association of this polymorphism with OTSC and identified a rare variant rs74503667 in a familial case. Here, we genotyped these variants in an Indian cohort composed of 254 OTSC cases and 262 controls. We detected a significant association of rs3914132 with OTSC (OR = 0.569, 95%CI = 0.386-0.838, p = 0.0041). To confirm this finding, we completed a meta-analysis which revealed a significant association of the rs3914132 polymorphism with OTSC (Z = 6.707, p<0.0001) across different ethnic populations. Linkage analysis found the evidence of linkage at RELN locus (LOD score 2.1059) in the OTSC family which has shown the transmission of rare variant rs74503667 in the affected individuals. To understand the role of RELN and its receptors in the development of OTSC, we went further to perform a functional analysis of RELN/reelin. Here we detected a reduced RELN (p = 0.0068) and VLDLR (p = 0.0348) mRNA levels in the otosclerotic stapes tissues. Furthermore, a reduced reelin protein expression by immunohistochemistry was confirmed in the otosclerotic tissues. Electrophoretic mobility shift assays for rs3914132 and rs74503667 variants revealed an altered binding of transcription factors in the mutated sequences which indicates the regulatory role of these variations in the RELN gene regulation. Subsequently, we showed by scanning electron microscopy a change in stapes bone morphology of otosclerotic patients. In conclusion, this study evidenced that the rare variation rs74503667 and the common polymorphism rs3914132 in the RELN gene and its reduced expressions that were associated with OTSC.

摘要

耳硬化症(otosclerosis,OTSC)是一种以人类中耳骨迷路异常重塑为特征的传导性听力损失的主要形式。RELN 基因 rs3914132 单核苷酸多态性与 OTSC 的遗传关联已在欧洲人群中得到鉴定。先前,我们发现该多态性与 OTSC 呈趋势相关,并在一个家族病例中鉴定出一种罕见变异 rs74503667。在此,我们对由 254 例 OTSC 患者和 262 例对照组成的印度队列进行了这些变体的基因分型。我们检测到 rs3914132 与 OTSC 显著相关(OR = 0.569,95%CI = 0.386-0.838,p = 0.0041)。为了证实这一发现,我们完成了一项荟萃分析,结果表明 rs3914132 多态性与 OTSC 显著相关(Z = 6.707,p<0.0001),这一关联存在于不同种族人群中。连锁分析在 OTSC 家族中发现了 RELN 基因座的连锁证据(LOD 得分 2.1059),该家族中 rs74503667 罕见变异在受影响个体中发生了传递。为了了解 RELN 及其受体在 OTSC 发展中的作用,我们进一步对 RELN/reelin 进行了功能分析。在此,我们检测到硬化镫骨组织中 RELN(p = 0.0068)和 VLDLR(p = 0.0348)mRNA 水平降低。此外,通过免疫组织化学进一步证实了硬化组织中 reelin 蛋白表达减少。对 rs3914132 和 rs74503667 变体的电泳迁移率变动分析显示,突变序列中转录因子的结合发生改变,这表明这些变异在 RELN 基因调控中具有调节作用。随后,我们通过扫描电子显微镜观察到硬化患者镫骨骨形态的变化。总之,这项研究证明了 RELN 基因中的罕见变异 rs74503667 和常见多态性 rs3914132 及其与 OTSC 相关的表达降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/42562c0bd343/pone.0269558.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/9462e72ac020/pone.0269558.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/fb408c37c758/pone.0269558.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/7a0969e9e62e/pone.0269558.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/9ab5243492bf/pone.0269558.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/22be8f2bde5c/pone.0269558.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/3bbb75b4c6f8/pone.0269558.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/42562c0bd343/pone.0269558.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/9462e72ac020/pone.0269558.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/fb408c37c758/pone.0269558.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/7a0969e9e62e/pone.0269558.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/9ab5243492bf/pone.0269558.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/22be8f2bde5c/pone.0269558.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/3bbb75b4c6f8/pone.0269558.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/9165908/42562c0bd343/pone.0269558.g007.jpg

相似文献

1
The risks of RELN polymorphisms and its expression in the development of otosclerosis.RELN 多态性及其表达在耳硬化症发展中的风险。
PLoS One. 2022 Jun 3;17(6):e0269558. doi: 10.1371/journal.pone.0269558. eCollection 2022.
2
Osteoprotegerin gene polymorphisms and otosclerosis: an additional genetic association study, multilocus interaction and meta-analysis.骨保护素基因多态性与耳硬化症:一项补充性基因关联研究、多位点相互作用及荟萃分析
BMC Med Genet. 2020 Jun 3;21(1):122. doi: 10.1186/s12881-020-01036-8.
3
Evidence of distinct RELN and TGFB1 genetic associations in familial and non-familial otosclerosis in a British population.在英国人群中,家族性和非家族性耳硬化症中存在 RELN 和 TGFB1 基因的不同遗传关联。
Hum Genet. 2018 May;137(5):357-363. doi: 10.1007/s00439-018-1889-9. Epub 2018 May 4.
4
Controversies in RELN/reelin expression in otosclerosis.耳硬化症中 RELN/reelin 表达的争议。
Eur Arch Otorhinolaryngol. 2012 Feb;269(2):431-40. doi: 10.1007/s00405-011-1653-4. Epub 2011 Jun 1.
5
Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility.TGFB1 的遗传关联和基因表达谱及其对耳硬化症易感性的贡献。
J Bone Miner Res. 2013 Dec;28(12):2490-7. doi: 10.1002/jbmr.1991.
6
Evaluation of the Genetic Association and mRNA Expression of the , , and Genes in the Development of Otosclerosis.评估 、 、 基因在耳硬化症发展中的遗传关联和 mRNA 表达。
Genet Test Mol Biomarkers. 2020 Jun;24(6):343-351. doi: 10.1089/gtmb.2019.0235. Epub 2020 May 5.
7
Genetic variants in RELN are associated with otosclerosis in a non-European population from Tunisia.在来自突尼斯的非欧洲人群中,RELN基因变异与耳硬化症相关。
Ann Hum Genet. 2010 Sep 1;74(5):399-405. doi: 10.1111/j.1469-1809.2010.00595.x. Epub 2010 Jul 14.
8
Lack of association between SNP rs3914132 of the RELN gene and otosclerosis in India.RELN基因单核苷酸多态性rs3914132与印度耳硬化症之间无关联。
Genet Mol Res. 2010 Sep 28;9(3):1914-20. doi: 10.4238/vol9-3gmr890.
9
Genetic variants and altered expression of SERPINF1 confer disease susceptibility in patients with otosclerosis.丝氨酸蛋白酶抑制剂因子 1 的遗传变异和表达改变使耳硬化症患者易患病。
J Hum Genet. 2023 Sep;68(9):635-642. doi: 10.1038/s10038-023-01158-w. Epub 2023 May 18.
10
Genetic association analysis in a clinically and histologically confirmed otosclerosis population confirms association with the TGFB1 gene but suggests an association of the RELN gene with a clinically indistinguishable otosclerosis-like phenotype.在经临床和组织学确诊的耳硬化症人群中进行的基因关联分析证实了与转化生长因子β1(TGFB1)基因的关联,但提示RELN基因与临床上难以区分的耳硬化症样表型存在关联。
Otol Neurotol. 2014 Jul;35(6):1058-64. doi: 10.1097/MAO.0000000000000334.

引用本文的文献

1
Exploring the genetic landscape of otosclerosis: current understanding and future perspectives.探索耳硬化症的遗传图谱:当前认识与未来展望。
Acta Otorhinolaryngol Ital. 2025 Jun;45(Suppl. 1):S2-S17. doi: 10.14639/0392-100X-suppl.1_3-45-2025-A1334.
2
Genetic variants and altered expression of SERPINF1 confer disease susceptibility in patients with otosclerosis.丝氨酸蛋白酶抑制剂因子 1 的遗传变异和表达改变使耳硬化症患者易患病。
J Hum Genet. 2023 Sep;68(9):635-642. doi: 10.1038/s10038-023-01158-w. Epub 2023 May 18.
3
Targeted Resequencing of Otosclerosis Patients from Different Populations Replicates Results from a Previous Genome-Wide Association Study.

本文引用的文献

1
Genetics of otosclerosis: finally catching up with other complex traits?耳硬化症的遗传学:终于要赶上其他复杂性状了吗?
Hum Genet. 2022 Apr;141(3-4):939-950. doi: 10.1007/s00439-021-02357-1. Epub 2021 Sep 9.
2
Reelin depletion alleviates multiple myeloma bone disease by promoting osteogenesis and inhibiting osteolysis.Reelin缺失通过促进成骨作用和抑制骨吸收来减轻多发性骨髓瘤骨病。
Cell Death Discov. 2021 Aug 25;7(1):219. doi: 10.1038/s41420-021-00608-8.
3
A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis.
对来自不同人群的耳硬化症患者进行靶向重测序,重复了先前全基因组关联研究的结果。
J Clin Med. 2022 Nov 26;11(23):6978. doi: 10.3390/jcm11236978.
聚集蛋白聚糖中广泛的保护性和易感性变异影响耳硬化症的易感性。
Hum Genet. 2022 Apr;141(3-4):951-963. doi: 10.1007/s00439-021-02334-8. Epub 2021 Aug 19.
4
Sensitivity analysis for publication bias in meta-analyses.Meta分析中发表偏倚的敏感性分析。
J R Stat Soc Ser C Appl Stat. 2020 Nov;69(5):1091-1119. doi: 10.1111/rssc.12440. Epub 2020 Aug 28.
5
Functional Analysis of S2486G Mutation and its Contribution to Pathogenesis of Ankylosing Spondylitis.S2486G 突变的功能分析及其对强直性脊柱炎发病机制的贡献。
Arch Iran Med. 2020 Oct 1;23(10):688-696. doi: 10.34172/aim.2020.87.
6
Osteoprotegerin gene polymorphisms and otosclerosis: an additional genetic association study, multilocus interaction and meta-analysis.骨保护素基因多态性与耳硬化症:一项补充性基因关联研究、多位点相互作用及荟萃分析
BMC Med Genet. 2020 Jun 3;21(1):122. doi: 10.1186/s12881-020-01036-8.
7
Evaluation of the Genetic Association and mRNA Expression of the , , and Genes in the Development of Otosclerosis.评估 、 、 基因在耳硬化症发展中的遗传关联和 mRNA 表达。
Genet Test Mol Biomarkers. 2020 Jun;24(6):343-351. doi: 10.1089/gtmb.2019.0235. Epub 2020 May 5.
8
Identification of RELN variant p.(Ser2486Gly) in an Iranian family with ankylosing spondylitis; the first association of RELN and AS.在一个伊朗强直性脊柱炎家系中鉴定 RELN 变异 p.(Ser2486Gly);RELN 与 AS 的首次关联。
Eur J Hum Genet. 2020 Jun;28(6):754-762. doi: 10.1038/s41431-020-0573-4. Epub 2020 Jan 30.
9
Reelin: Diverse roles in central nervous system development, health and disease.Reelin:中枢神经系统发育、健康和疾病中的多种作用。
Int J Biochem Cell Biol. 2019 Jul;112:72-75. doi: 10.1016/j.biocel.2019.04.009. Epub 2019 Apr 22.
10
A Biochemical Analysis of the Stapes.镫骨的生化分析。
Med Sci Monit. 2019 Apr 12;25:2679-2686. doi: 10.12659/MSM.913635.